Sarah Maskri, Ph.D.

Sarah Maskri, Ph.D. has seven years of work experience in various research roles. Sarah currently works as a Research Scientist at Sosei Heptares, where they focus on the discovery and early development of new medicines. Prior to this, they worked as a Doctoral research associate at the Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation. Sarah also has experience as a Visiting Ph.D. at the University of Oxford and The Mount Sinai Hospital, where they studied molecular mechanisms and drug discovery related to ion channels and GPCRs. Sarah has also worked as a Research Assistant at the University of New England, where they focused on drug discovery targeting protein kinases. Additionally, they have interned at S3F CHIMIE SOCIETE CHIMIQUE DE FABRICATION DE PRODUITS FLUORES.

Sarah Maskri, Ph.D. has a diverse education history. In 2011, they received their High School Diploma with a focus on Mathematics, Physics, and Chemistry from Public High School Abbane Ramdane Tizi-Ouzou. From 2014 to 2017, they pursued a BSc Degree in Chemistry/Biochemistry at the University of Montpellier in France. In 2017, they participated in a Franco-Italian double MSc degree program in Chemoinformatics at the University of Strasbourg in France. In 2018, they continued their studies with a Franco-Italian double MSc degree in In silico Drug Design at Université Paris Cité in France. Additionally, in the same year, they completed a Franco-Italian double MSc degree in Industrial and Medicinal chemistry at Università degli Studi di Milano in Italy. Currently, Sarah is a Ph.D. candidate at the University of Münster in Germany, specializing in Computational Medicinal Chemistry and Molecular Design.